spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  tumor-activated 

 HSMN NewsFeed - 12 Feb 2025
AbbVie and Xilio Therapeutics Announce Collaboration and Option Agreement to Develop Novel Tumor-Activated Immunotherapies
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 29 Jul 2010
Abraxis BioScience and Specialised Therapeutics Announce Approval to Market ABRAXANE for Metastatic Breast Cancer in New Zealand
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 23 Jul 2010
ABRAXANE(R) Approved for Marketing in Japan for Breast Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 30 Jun 2010
Celgene to Acquire Abraxis BioScience Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 8 Jun 2010
New ABRAXANE(R) Data Demonstrates Potential in Patients with Advanced and Malignant Melanoma, Among the Toughest Cancers to Treat
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Aug 2008
ImmunoGen, Inc. Announces sanofi-aventis Licenses Expanded Access to the Company's TAP Technology
Biopharmaceuticals Licensing
 HSMN NewsFeed - 5 Aug 2008
Telik Names Stefan Ryser, Ph.D. Senior Vice President, Corporate Strategy
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Jul 2008
ImmunoGen, Inc. Announces Senior Management Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Nov 2007
ImmunoGen, Inc. Hires John Tagliamonte as Vice President, Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Oct 2007
FDA Removes Partial Hold on TELCYTA Clinical Development
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 3 Oct 2007
ImmunoGen, Inc. Hires Craig Barrows as Vice President, General Counsel and Secretary
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Jul 2007
ImmunoGen, Inc. Announces Departure of Pauline Jen Ryan
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Jun 2007
FDA Converts TELCYTA Full Clinical Hold to Partial Hold
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 3 Jun 2007
Telik Reports Results of TELCYTA(R) Assist-3 Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Jun 2007
Telik Announces Top-Line Results of TELCYTA(R) ASSIST-2 Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Jun 2007
Telik Reports Results of TELCYTA(R) ASSIST-1 Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Jun 2007
ImmunoGen, Inc. Announces Clinical Data Reported at ASCO
Biopharmaceuticals Drug Delivery Oncology
 HSMN NewsFeed - 17 Apr 2007
Telik Reports Positive Data Demonstrating Synergy in Combination and Highly Statistically Significant Effect of TELCYTA as Maintenance Therapy in First-Line Non-Small Cell Lung Cancer
Biopharmacetuicals Oncology
 HSMN NewsFeed - 6 Mar 2007
ImmunoGen, Inc. Announces Departure of Walter Blattler
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Dec 2006
ImmunoGen, Inc. Announces that sanofi-aventis Has Entered into an Option Agreement for Expanded Access to the Company's TAP Technology
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 25 Sep 2006
Telik Updates ASSIST-1 Status
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Jul 2006
ImmunoGen, Inc. Grants Biotest AG Rights to Use ImmunoGen TAP Technology to Develop Novel Anticancer Therapeutics
Biopharmaceuticals Licensing
 HSMN NewsFeed - 4 May 2006
ImmunoGen, Inc. to Develop Commercial-Scale Manufacturing Process for Trastuzumab-DM1 for Genentech
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 21

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 21 additional stories matching:
tumor-activated
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.